Clarivate Reports Strong FY 2025 Growth and Optimistic 2026 Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 04 2026
0mins
Should l Buy CLVT?
Source: NASDAQ.COM
Clarivate PLC's stock surged by 30.95% as it crossed above the 5-day SMA, reflecting strong investor confidence following its recent financial disclosures.
The company reported nearly 2% organic Annual Contract Value (ACV) growth for FY 2025, driven by optimized business models and enhanced sales execution. Additionally, Clarivate generated $365.3 million in free cash flow, a 2.2% increase from the previous year, allowing for significant shareholder returns through share repurchases. The strategic review of its Life Sciences & Healthcare business is expected to further strengthen its focus on Academia & Government and Intellectual Property markets, enhancing its financial position. The company anticipates organic ACV growth of 2% to 3% for 2026, with projected Adjusted EBITDA between $980 million and $1.04 billion, indicating sustained momentum.
These results highlight Clarivate's robust financial health and strategic direction, positioning it well for future growth. The positive outlook for 2026, coupled with strong cash flow performance, suggests that the company is on a solid path to enhance shareholder value and market competitiveness.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CLVT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CLVT
Wall Street analysts forecast CLVT stock price to rise
5 Analyst Rating
0 Buy
3 Hold
2 Sell
Moderate Sell
Current: 2.810
Low
3.00
Averages
3.90
High
5.00
Current: 2.810
Low
3.00
Averages
3.90
High
5.00
About CLVT
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company offers solutions across various areas, which include scientific and academic research, information solutions and library software. Its ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats, including data bases, dissertations, news, primary sources, books, and video. Within the IP segment, the Company provides IP data, software, and expertise to other companies to manage and protect critical IP assets. This segment's service offerings include IP management software, Patent services and Brand IP solutions, among others. Within the LS&H segment, the Company offers solutions across research and development, commercial and Medtech.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Clarivate Launches Global Research Intelligence Platform
- Global Launch: Clarivate Plc announced the global launch of the Web of Science Research Intelligence platform on May 6, 2026, designed to support research institutions in funding, strategy, and impact decisions through AI-driven insights, marking a significant advancement in research intelligence.
- Collaborative Development: Developed in partnership with over 50 collaborators across 20 countries, the platform ensures alignment with real institutional needs, enhancing capabilities in securing funding and building collaboration networks for research institutions.
- Multidimensional Impact Framework: The platform helps institutions move beyond traditional productivity metrics by using multidimensional indicators to clearly articulate the societal impact of research, thereby enhancing the visibility of research contributions to policy and social outcomes.
- Data Integration Advantage: By integrating authoritative data from sources like the Web of Science Core Collection, the platform provides a reliable foundation for decision-making, ensuring transparency and traceability in research decisions, which boosts institutional confidence in high-stakes scenarios.
See More
Clarivate Launches Global Research Intelligence Platform
- Global Launch: On May 6, 2026, Clarivate Plc announced the global launch of the Web of Science Research Intelligence platform, designed to support research institutions in funding, strategy, and impact decisions through AI-driven insights, marking a significant advancement in research intelligence.
- Collaborative Development: Developed in partnership with over 50 collaborators across 20 countries, the platform ensures its features align closely with actual research needs, thereby enhancing institutions' capabilities in securing funding and fostering collaboration, which strengthens their competitive position in academia.
- Data Integration: Web of Science Research Intelligence integrates data from publications, patents, funding, policy documents, and clinical trials into a single reliable foundation for decision-making, helping institutions effectively demonstrate the societal impact of their research and drive changes in policy and practice.
- AI-Driven Workflows: The platform's AI-guided workflows enable more users to contribute to research planning and strategy, not only increasing analysis speed but also enhancing decision confidence and clarity in communicating research value, further promoting the societal contributions of research.
See More
Clarivate's Strong Earnings Propel Stock Surge Over 18%
- Quarterly Revenue Performance: Clarivate reported first-quarter revenue just under $586 million, reflecting a slight 1% year-over-year decline, yet it surpassed analyst expectations of $569 million, demonstrating the company's competitive position in the market.
- Net Income Growth: The company's net income under GAAP rose nearly 25% to over $119 million ($0.18 per share), indicating a significant improvement in profitability and operational efficiency.
- Value Creation Plan: CEO Matti Shem Tov highlighted that the value creation plan launched in early 2025 is a key driver of performance improvement, aimed at simplifying the business model, enhancing commercial effectiveness, and accelerating innovation across the portfolio.
- Full-Year Guidance: Management reaffirmed its full-year revenue guidance of $2.30 billion to $2.42 billion and adjusted earnings per share guidance of $0.70 to $0.80, reflecting confidence in the company's growth trajectory amid ongoing strategic initiatives.
See More
Clarivate Q1 2026 Earnings Call Insights
- Consistent Performance Improvement: Clarivate reported Q1 2026 adjusted EPS of $0.18, surpassing analysts' expectations of $0.14, with revenues reaching $586 million, indicating ongoing progress in executing its Value Creation Plan, which is expected to drive full-year performance targets.
- Accelerated AI Innovation: CEO Matti Shem Tov emphasized the company's intensified investment in AI, particularly through new products like the 'Wave 1 AI Assistant', which is anticipated to significantly enhance customer efficiency, thereby strengthening the company's competitive position and profit margins.
- Expansion in China: Clarivate secured 15 new Web of Science contracts in China over the past year, demonstrating strong performance in this rapidly growing market, with potential for further increasing its market share in the Asia-Pacific region.
- Reaffirmed Financial Guidance: CFO Jonathan Collins reaffirmed the full-year financial guidance, including projected revenue of $2.36 billion and free cash flow of $400 million, while acknowledging potential divestiture risks, the company maintains an optimistic outlook for future growth.
See More
Clarivate Reports Q1 Growth Driven by Value Creation Plan
- Strong Financial Performance: Clarivate reported total revenues of $585.5 million for Q1, reflecting a 1.4% year-over-year decline, yet organic revenue growth of 0.6% indicates the company's execution strength and market adaptability under the Value Creation Plan.
- Robust Free Cash Flow: The company generated $78.9 million in free cash flow during the first quarter, reflecting strong adjusted EBITDA performance and financial discipline, which was further utilized to retire $143 million in debt, thereby strengthening the balance sheet.
- Significant Improvement in Net Loss: The net loss for Q1 improved to $40.2 million, or $0.06 per share, compared to a net loss of $103.9 million in the same period last year, marking a 61.3% improvement and showcasing positive progress in profitability.
- 2026 Outlook Reaffirmed: Clarivate reaffirmed its financial outlook for 2026, including expectations for approximately $400 million in free cash flow and adjusted EBITDA projected between $980 million and $1.04 billion, demonstrating confidence in future growth and a clear strategic direction.
See More
Clarivate Reports Q1 Results Highlighting Growth Potential
- Financial Recovery: Clarivate reported total revenues of $585.5 million for Q1, down 1.4% from $593.7 million last year, yet organic revenue growth of 0.6% indicates steady recovery under the Value Creation Plan.
- Strong Free Cash Flow: The company generated $79 million in free cash flow during Q1, a 28.5% decline from $110.3 million last year, but effectively reduced $143 million in debt through strong adjusted EBITDA performance and financial discipline, further strengthening its balance sheet.
- Significant Improvement in Net Loss: The net loss for Q1 was $40.2 million, or $0.06 per share, compared to a net loss of $103.9 million and $0.15 per share last year, showcasing a notable improvement in profitability.
- 2026 Outlook Reaffirmed: Clarivate reaffirmed its 2026 financial outlook, projecting revenues between $2.3 billion and $2.42 billion, with adjusted EBITDA expected between $980 million and $1.04 billion, reflecting the company's confidence in future growth.
See More
Clarivate Launches Global Research Intelligence Platform
- Global Launch: Clarivate Plc announced the global launch of the Web of Science Research Intelligence platform on May 6, 2026, designed to support research institutions in funding, strategy, and impact decisions through AI-driven insights, marking a significant advancement in research intelligence.
- Collaborative Development: Developed in partnership with over 50 collaborators across 20 countries, the platform ensures alignment with real institutional needs, enhancing capabilities in securing funding and building collaboration networks for research institutions.
- Multidimensional Impact Framework: The platform helps institutions move beyond traditional productivity metrics by using multidimensional indicators to clearly articulate the societal impact of research, thereby enhancing the visibility of research contributions to policy and social outcomes.
- Data Integration Advantage: By integrating authoritative data from sources like the Web of Science Core Collection, the platform provides a reliable foundation for decision-making, ensuring transparency and traceability in research decisions, which boosts institutional confidence in high-stakes scenarios.
See More
Clarivate Launches Global Research Intelligence Platform
- Global Launch: On May 6, 2026, Clarivate Plc announced the global launch of the Web of Science Research Intelligence platform, designed to support research institutions in funding, strategy, and impact decisions through AI-driven insights, marking a significant advancement in research intelligence.
- Collaborative Development: Developed in partnership with over 50 collaborators across 20 countries, the platform ensures its features align closely with actual research needs, thereby enhancing institutions' capabilities in securing funding and fostering collaboration, which strengthens their competitive position in academia.
- Data Integration: Web of Science Research Intelligence integrates data from publications, patents, funding, policy documents, and clinical trials into a single reliable foundation for decision-making, helping institutions effectively demonstrate the societal impact of their research and drive changes in policy and practice.
- AI-Driven Workflows: The platform's AI-guided workflows enable more users to contribute to research planning and strategy, not only increasing analysis speed but also enhancing decision confidence and clarity in communicating research value, further promoting the societal contributions of research.
See More
Clarivate's Strong Earnings Propel Stock Surge Over 18%
- Quarterly Revenue Performance: Clarivate reported first-quarter revenue just under $586 million, reflecting a slight 1% year-over-year decline, yet it surpassed analyst expectations of $569 million, demonstrating the company's competitive position in the market.
- Net Income Growth: The company's net income under GAAP rose nearly 25% to over $119 million ($0.18 per share), indicating a significant improvement in profitability and operational efficiency.
- Value Creation Plan: CEO Matti Shem Tov highlighted that the value creation plan launched in early 2025 is a key driver of performance improvement, aimed at simplifying the business model, enhancing commercial effectiveness, and accelerating innovation across the portfolio.
- Full-Year Guidance: Management reaffirmed its full-year revenue guidance of $2.30 billion to $2.42 billion and adjusted earnings per share guidance of $0.70 to $0.80, reflecting confidence in the company's growth trajectory amid ongoing strategic initiatives.
See More
Clarivate Q1 2026 Earnings Call Insights
- Consistent Performance Improvement: Clarivate reported Q1 2026 adjusted EPS of $0.18, surpassing analysts' expectations of $0.14, with revenues reaching $586 million, indicating ongoing progress in executing its Value Creation Plan, which is expected to drive full-year performance targets.
- Accelerated AI Innovation: CEO Matti Shem Tov emphasized the company's intensified investment in AI, particularly through new products like the 'Wave 1 AI Assistant', which is anticipated to significantly enhance customer efficiency, thereby strengthening the company's competitive position and profit margins.
- Expansion in China: Clarivate secured 15 new Web of Science contracts in China over the past year, demonstrating strong performance in this rapidly growing market, with potential for further increasing its market share in the Asia-Pacific region.
- Reaffirmed Financial Guidance: CFO Jonathan Collins reaffirmed the full-year financial guidance, including projected revenue of $2.36 billion and free cash flow of $400 million, while acknowledging potential divestiture risks, the company maintains an optimistic outlook for future growth.
See More
Clarivate Reports Q1 Growth Driven by Value Creation Plan
- Strong Financial Performance: Clarivate reported total revenues of $585.5 million for Q1, reflecting a 1.4% year-over-year decline, yet organic revenue growth of 0.6% indicates the company's execution strength and market adaptability under the Value Creation Plan.
- Robust Free Cash Flow: The company generated $78.9 million in free cash flow during the first quarter, reflecting strong adjusted EBITDA performance and financial discipline, which was further utilized to retire $143 million in debt, thereby strengthening the balance sheet.
- Significant Improvement in Net Loss: The net loss for Q1 improved to $40.2 million, or $0.06 per share, compared to a net loss of $103.9 million in the same period last year, marking a 61.3% improvement and showcasing positive progress in profitability.
- 2026 Outlook Reaffirmed: Clarivate reaffirmed its financial outlook for 2026, including expectations for approximately $400 million in free cash flow and adjusted EBITDA projected between $980 million and $1.04 billion, demonstrating confidence in future growth and a clear strategic direction.
See More
Clarivate Reports Q1 Results Highlighting Growth Potential
- Financial Recovery: Clarivate reported total revenues of $585.5 million for Q1, down 1.4% from $593.7 million last year, yet organic revenue growth of 0.6% indicates steady recovery under the Value Creation Plan.
- Strong Free Cash Flow: The company generated $79 million in free cash flow during Q1, a 28.5% decline from $110.3 million last year, but effectively reduced $143 million in debt through strong adjusted EBITDA performance and financial discipline, further strengthening its balance sheet.
- Significant Improvement in Net Loss: The net loss for Q1 was $40.2 million, or $0.06 per share, compared to a net loss of $103.9 million and $0.15 per share last year, showcasing a notable improvement in profitability.
- 2026 Outlook Reaffirmed: Clarivate reaffirmed its 2026 financial outlook, projecting revenues between $2.3 billion and $2.42 billion, with adjusted EBITDA expected between $980 million and $1.04 billion, reflecting the company's confidence in future growth.
See More
